Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Adefovir dipivoxil ester colalin derivatives as well as preparation method and uses thereof

A technology for adefovir dipivoxil and its derivatives, which is applied in the field of adefovir dipivoxil cholic acid derivatives and its preparation, and can solve problems that do not involve adefovir dipivoxil cholic acid derivatives

Inactive Publication Date: 2008-05-21
CHINA PHARM UNIV
View PDF8 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

None of the above patents involved adefovir dipivoxil cholic acid derivatives, nor did they mention that adefovir dipivoxil cholic acid derivatives have the characteristics of liver targeting

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Adefovir dipivoxil ester colalin derivatives as well as preparation method and uses thereof
  • Adefovir dipivoxil ester colalin derivatives as well as preparation method and uses thereof
  • Adefovir dipivoxil ester colalin derivatives as well as preparation method and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0058] Embodiment 1 The structural formula of adefovir dipivoxil bile acid conjugates

[0059] Formula 9:

[0060]

[0061] where R 1 , R 2 , R 3 and R 4 are a hydrogen atom or a hydroxyl group, respectively.

Embodiment 2

[0062] The structural formula of embodiment 2 adefovir dipivoxil bile acid salts

[0063] Formula 10:

[0064]

[0065] Where X is -OH, -NH-(CH 2 ) n SO 3 H,, -NH-(CH 2 ) n -CO 2 H (wherein n is an integer of 1-3).

Embodiment 3

[0066] The structural formula of embodiment 3 adefovir dipivoxil bile acid salts

[0067] Formula 11:

[0068]

[0069]where R 1 , R 2 , R 3 and R 4 Respectively hydrogen atom or hydroxyl; Wherein X is -OH, -NH-(CH 2 ) n SO 3 H,, -NH-(CH 2 ) n -CO 2 H (wherein n is an integer of 1-3).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses an adefovir dipivoxil cholic acid class derivative and also relates to a preparation method and applications thereof at the medical aspect. The adefovir dipivoxil cholic acid class derivative is a hepatic targeting precursor drug of adefovir; compared with the adefovir dipivoxil, the adefovir dipivoxil cholic acid class derivative can improve the concentration of the adefovir in liver after being taken orally, and the adefovir dipivoxil cholic acid class derivative can be used as a preferential drug for the treatment of resisting virus and especially resisting hepatitis virus.

Description

Technical field: [0001] The invention relates to the technical field of medicine, specifically adefovir dipivoxil cholic acid derivatives, a preparation method and application thereof. Background technique: [0002] Adefovir dipivoxil chemical name: 9-[2-[bis(pivaloyloxymethoxy)phosphorylmethoxy]ethyl]adenine, CA accession number is [142340-99- 6], molecular formula: C 20 h 32 N 5 o 8 P, its structural formula is as formula 1: [0003] [0004] Adefovir dipivoxil is the prodrug of adefovir, which is a purine derivative. It can be taken orally and hydrolyzed into adefovir after oral administration. It has antiviral effect without phosphorylation. This product can inhibit the activity of HBV DNA polymerase, and can penetrate into the DNA of hepatitis B virus to inhibit the replication of the virus. It has a strong inhibitory effect on HBV virus strains resistant to lamivudine and famciclovir. It is used clinically Hepatitis treatment. [0005] The earliest compound p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07F9/6561C07J9/00A61K47/48A61K31/675A61P1/16A61K47/54
Inventor 周建平张振海吕慧侠张磊谢俊郭伟程玉钏张辉李悦恒吴益平
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products